MPR YIR RA 2019 Archives - MPR

MPR YIR RA 2019

RediTrex Approved for RA, pJIA, Psoriasis Treatment

The FDA has approved RediTrex (methotrexate injection; Cumberland) for the management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis, who are intolerant of or had an inadequate response to first-line therapy.